• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在三维小鼠乳腺癌模型中,NK1受体阻断可破坏微肿瘤的生长和聚集。

NK1 receptor blockade disrupts microtumor growth and aggregation in a three-dimensional murine breast cancer model.

作者信息

Gutierrez Silvia, Boada M Danilo

机构信息

Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

出版信息

Neuropeptides. 2025 Jan;109:102479. doi: 10.1016/j.npep.2024.102479. Epub 2024 Oct 16.

DOI:10.1016/j.npep.2024.102479
PMID:39591909
Abstract

Several data indicate that Substance P (SP) neurokinin type 1 receptor (NK1R) is at the center of the interaction between cancer cells and peripheral sensory neurons. Selecting the appropriate cancer cell line and its susceptibility to being modulated by NK1 antagonists are critical to studying this complex interaction. In the current study, we have focused on this selection by comparing several aspects of the triple-negative breast cancer (TNBC) cell line (MDA-MB-231) with a modified murine cell line (E0771), both expressing luciferase. This comparison was made using several methods, SP stimulation and 3D cell culture models, to better reproduce the heterogenous microenvironment of solid tumors observed in vivo. Furthermore, the susceptibility of the murine cell line (E0771) to NK1R antagonist (Aprepitant) was tested. Our results indicate that E0771 recapitulates several essential aspects of the human cell line, rendering this murine line ideal to be used on immune-competent animals during in vivo studies. We have also found that both cell lines are susceptible to SP stimulation, and their proliferation is disrupted by NK1R antagonists (Aprepitant). In vivo studies are required to verify and refine these findings.

摘要

多项数据表明,P物质(SP)神经激肽1型受体(NK1R)处于癌细胞与外周感觉神经元相互作用的核心。选择合适的癌细胞系及其对NK1拮抗剂调节的敏感性对于研究这种复杂的相互作用至关重要。在当前研究中,我们通过比较三阴性乳腺癌(TNBC)细胞系(MDA-MB-231)与改良的小鼠细胞系(E0771)的几个方面来专注于这种选择,这两种细胞系均表达荧光素酶。使用多种方法进行了这种比较,包括SP刺激和3D细胞培养模型,以更好地重现体内观察到的实体瘤的异质微环境。此外,还测试了小鼠细胞系(E0771)对NK1R拮抗剂(阿瑞匹坦)的敏感性。我们的结果表明,E0771概括了人类细胞系的几个基本方面,使该小鼠细胞系成为体内研究中用于免疫健全动物的理想选择。我们还发现,两种细胞系均对SP刺激敏感,并且它们的增殖被NK1R拮抗剂(阿瑞匹坦)破坏。需要进行体内研究来验证和完善这些发现。

相似文献

1
NK1 receptor blockade disrupts microtumor growth and aggregation in a three-dimensional murine breast cancer model.在三维小鼠乳腺癌模型中,NK1受体阻断可破坏微肿瘤的生长和聚集。
Neuropeptides. 2025 Jan;109:102479. doi: 10.1016/j.npep.2024.102479. Epub 2024 Oct 16.
2
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.肝癌细胞表达截断的神经激肽-1 受体,阿瑞匹坦可在体外和体内抑制其生长。
J Hepatol. 2014 May;60(5):985-94. doi: 10.1016/j.jhep.2013.12.024. Epub 2014 Jan 8.
3
Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.神经激肽受体1和2拮抗剂在转移性乳腺癌细胞中的不同作用;与P物质无关的效应
Biomed Pharmacother. 2018 Dec;108:263-270. doi: 10.1016/j.biopha.2018.09.013. Epub 2018 Sep 14.
4
Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.靶向 SP/NK1R 系统治疗宫颈癌的体外潜在疗效。
Mol Biol Rep. 2022 Feb;49(2):1067-1076. doi: 10.1007/s11033-021-06928-3. Epub 2021 Nov 12.
5
SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.SP/NK1R 系统调控前列腺癌的发生:阐明阿瑞匹坦的抗肿瘤功能。
Biochim Biophys Acta Mol Cell Res. 2022 May;1869(5):119221. doi: 10.1016/j.bbamcr.2022.119221. Epub 2022 Feb 5.
6
The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.SP/NK1R 系统通过 NF-κB 介导的炎症反应促进乳腺癌细胞的增殖。
Cell Biochem Biophys. 2023 Dec;81(4):787-794. doi: 10.1007/s12013-023-01171-y. Epub 2023 Sep 23.
7
TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.TGFβ 调节 NK1R-Tr 影响乳腺癌细胞的增殖和凋亡。
Life Sci. 2020 Sep 1;256:117674. doi: 10.1016/j.lfs.2020.117674. Epub 2020 May 5.
8
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.miR-34b/c-5p 和神经激肽-1 受体调节乳腺癌细胞的增殖和凋亡。
Cell Prolif. 2019 Jan;52(1):e12527. doi: 10.1111/cpr.12527. Epub 2018 Oct 17.
9
Antiproliferative effects of [D-Pro2, D-Trp7,9]-Substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells.[D-脯氨酸2,D-色氨酸7,9]-P物质和阿瑞匹坦对几种癌细胞系的抗增殖作用及其与正常细胞相比的选择性。
Folia Neuropathol. 2020;58(3):237-244. doi: 10.5114/fn.2020.100066.
10
The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.阿瑞匹坦阻断神经激肽-1 受体对人卵巢癌细胞炎症和凋亡通路的影响。
Cell Biochem Biophys. 2022 Dec;80(4):819-827. doi: 10.1007/s12013-022-01100-5. Epub 2022 Oct 5.

引用本文的文献

1
A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen.一种使用阿瑞匹坦、伏硫西汀、罗氟司特和奥氮平的胶质母细胞瘤新辅助治疗方案:AVRO方案。
Int J Mol Sci. 2025 Jun 26;26(13):6158. doi: 10.3390/ijms26136158.
2
The Missing Link: Integrating Interventional Pain Management in the Era of Multimodal Oncology.缺失的环节:在多模式肿瘤学时代整合介入性疼痛管理
Pain Ther. 2025 Jun 17. doi: 10.1007/s40122-025-00755-1.